Plasma dehydroepiandrosterone sulfate and cardiovascular disease risk in older men and women

Authors

Xiaoming Jia, Baylor College of Medicine, Houston, Texas
Caroline Sun, Baylor College of Medicine, Houston, Texas
Olive Tang, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Ivan Gorlov, Baylor College of Medicine, Houston, Texas
Vijay Nambi, Baylor College of Medicine, Houston, Texas
Salim S. Virani, Baylor College of Medicine, Houston, TexasFollow
Dennis T. Villareal, Baylor College of Medicine, Houston, Texas
George E. Taffet, Baylor College of Medicine, Houston, Texas
Bing Yu, University of Texas Health Science Center at Houston, Houston, Texas
Jan Bressler, University of Texas Health Science Center at Houston, Houston, Texas

Document Type

Article

Department

Cardiology

Abstract

Context: Lower dehydroepiandrosterone-sulfate (DHEA-S) levels have been inconsistently associated with coronary heart disease (CHD) and mortality. Data are limited for heart failure (HF) and association between DHEA-S change and events.
Objective: Assess associations between low DHEA-S/DHEA-S change and incident HF hospitalization, CHD, and mortality in older adults.
Design: DHEA-S was measured in stored plasma from visits 4 (1996-1998) and 5 (2011-2013) of the Atherosclerosis Risk in Communities study. Follow-up for incident events: 18 years for DHEA-S level; 5.5 years for DHEA-S change.
Setting: General community.
Participants: Individuals without prevalent cardiovascular disease (n = 8143, mean age 63 years).
Main outcome measure: Associations between DHEA-S and incident HF hospitalization, CHD, or mortality; associations between 15-year change in DHEA-S (n = 3706) and cardiovascular events.
Results: DHEA-S below the 15th sex-specific percentile of the study population (men: 55.4 µg/dL; women: 27.4 µg/dL) was associated with increased HF hospitalization (men: hazard ratio [HR] 1.30, 95% confidence interval [CI], 1.07-1.58; women: HR 1.42, 95% CI, 1.13-1.79); DHEA-S below the 25th sex-specific percentile (men: 70.0 µg/dL; women: 37.1 µg/dL) was associated with increased death (men: HR 1.12, 95% CI, 1.01-1.25; women: HR 1.19, 95% CI, 1.03-1.37). In men, but not women, greater percentage decrease in DHEA-S was associated with increased HF hospitalization (HR 1.94, 95% CI, 1.11-3.39). Low DHEA-S and change in DHEA-S were not associated with incident CHD.
Conclusions: Low DHEA-S is associated with increased risk for HF and mortality but not CHD. Further investigation is warranted to evaluate mechanisms underlying these associations

Comments

This work was published before the author joined Aga Khan University.

Publication (Name of Journal)

The Journal of clinical endocrinology and metabolism

Recommended Citation

Jia, X., Sun, C., Tang, O., Gorlov, I., Nambi, V., Virani, S. S., Villareal, D. T., Taffet, G. E., Yu, B., Bressler, J. (2020). Plasma dehydroepiandrosterone sulfate and cardiovascular disease risk in older men and women. The Journal of clinical endocrinology and metabolism, 105(12), e4304-e4327.
Available at: https://ecommons.aku.edu/provost_office/288